Status:
WITHDRAWN
Adherence to Universal Aspirin Compared to Screening Indicated Aspirin for Prevention of Preeclampsia
Lead Sponsor:
Women and Infants Hospital of Rhode Island
Conditions:
Medication Adherence
Preeclampsia
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
There are data showing that a majority of pregnant women may not be accurately identified as high risk through screening and therefore, not receiving prophylactic low dose aspirin as recommended. This...
Detailed Description
Research objective- To compare adherence to low dose, 81mg of aspirin in women considered high risk by USPSTF criteria vs universal receipt. Hypothesis: Women considered high risk by USPSTF criteria ...
Eligibility Criteria
Inclusion
- Pregnancy between 10 to 20 weeks gestation by best available dating
- 18 years of age or older
- Fluency in English or Spanish
Exclusion
- • Contraindication to aspirin use
Key Trial Info
Start Date :
March 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04797949
Start Date
March 3 2021
End Date
June 1 2022
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women and Infants Hospital
Providence, Rhode Island, United States, 02905